New York, NY, United States of America

Ashley L Dumont

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2013-2023

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Ashley L. Dumont

Introduction: Ashley L. Dumont, a notable inventor based in New York, NY, has made significant contributions to the field of biomedical research. With a total of five patents to her name, Dumont's innovative work is pivotal in the development of therapeutic applications aimed at treating acute inflammatory conditions and infections.

Latest Patents: Among her latest patents is a bi-component leukocidin known as LukAB, which comprises two critical components: LukA and LukB. These patents disclose various applications, such as isolated and purified leukocidins, specific antibodies, and therapeutic compositions that utilize LukA and/or LukB. Additionally, there are methods outlined for identifying inhibitors of LukAB-mediated cytotoxicity of human phagocytes, as well as employing LukAB as a marker to predict the severity of infections.

Career Highlights: Ashley L. Dumont has established herself as a key figure in her field, working at New York University where she conducts advanced research. Her innovative spirit and dedication have led to breakthroughs that hold the potential to improve human health.

Collaborations: One of her notable collaborators is Victor J. Torres, with whom she has worked closely to push the boundaries of research in her area of expertise.

Conclusion: Through her inventive spirit and dedication to her research, Ashley L. Dumont is making a meaningful impact in the world of therapeutics. Her work continues to pave the way for advancements in the treatment of acute inflammatory conditions and infections, showcasing the importance of innovation in biomedical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…